Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
Anas Shamsi, Saleha Anwar, Taj Mohammad, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 789-789
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs
Arash Sadri
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 12651-12677
Closed Access | Times Cited: 59
Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy
Rashmi Dahiya, Taj Mohammad, Sonam Roy, et al.
International Journal of Biological Macromolecules (2019) Vol. 136, pp. 1076-1085
Closed Access | Times Cited: 95
Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer’s disease
Jielin Xu, Chengsheng Mao, Yuan Hou, et al.
Cell Reports (2022) Vol. 41, Iss. 9, pp. 111717-111717
Open Access | Times Cited: 48
Role of Impaired Mitochondrial Dynamics Processes in the Pathogenesis of Alzheimer’s Disease
Alexander V. Blagov, Andrey V. Grechko, Nikita G. Nikiforov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6954-6954
Open Access | Times Cited: 39
Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy
Mohd Yousuf, Parvez Κhan, Anas Shamsi, et al.
ACS Omega (2020) Vol. 5, Iss. 42, pp. 27480-27491
Open Access | Times Cited: 66
Transition Metal‐Free Synthesis of Carbamates Using CO2 as the Carbon Source
Waldemar Schilling, Shoubhik Das
ChemSusChem (2020) Vol. 13, Iss. 23, pp. 6246-6258
Open Access | Times Cited: 58
Structure‐based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases
Saleha Anwar, Shama Khan, Anas Shamsi, et al.
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 10, pp. 1445-1459
Closed Access | Times Cited: 53
High-Throughput Screening and Molecular Dynamics Simulation of Natural Product-like Compounds against Alzheimer’s Disease through Multitarget Approach
Danish Iqbal, Md Tabish Rehman, Abdulaziz Bin Dukhyil, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 937-937
Open Access | Times Cited: 44
Curcumin Scaffold as a Multifunctional Tool for Alzheimer’s Disease Research
Haijun Yang, Fantian Zeng, Yunchun Luo, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3879-3879
Open Access | Times Cited: 28
Comprehensive insight into the molecular interaction of rutin with human transferrin: Implication of natural compounds in neurodegenerative diseases
Anas Shamsi, Mohammad Furkan, Rizwan Hasan Khan, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126643-126643
Closed Access | Times Cited: 17
Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease
Saleha Anwar, Taj Mohammad, Md. Khabeer Azhar, et al.
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125364-125364
Closed Access | Times Cited: 16
Amyloid-induced neurodegeneration: A comprehensive review through aggregomics perception of proteins in health and pathology
Sania Bashir, Ayesha Aiman, Mohammad Shahid, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102276-102276
Closed Access | Times Cited: 6
Insight into the effect of ZIF-8 on the interaction between drugs and protein/cell
Ying Zheng, Xinyue Duan, Xin Wang, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139530-139530
Closed Access
Apigenin-mediated MARK4 inhibition: a novel approach in advancing Alzheimer’s disease therapeutics
Afzal Hussain, Deeba Shamim Jairajpuri, Saleha Anwar, et al.
Molecular Diversity (2025)
Closed Access
Identification of potential inhibitors of Fyn-Kinase from bioactive phytochemicals of Berberis lycium for therapeutic targeting of neurodegenerative disease
Sneh Prabha, Arunabh Choudhury, Juhi Saraswat, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-18
Closed Access
Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer’s disease
Ahmad Abu Turab Naqvi, Deeba Shamim Jairajpuri, Omar M. Noman, et al.
Journal of Biomolecular Structure and Dynamics (2019) Vol. 38, Iss. 13, pp. 3892-3907
Closed Access | Times Cited: 44
Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases
Saleha Anwar, Anas Shamsi, Rajiv K. Kar, et al.
International Journal of Biological Macromolecules (2020) Vol. 161, pp. 596-604
Closed Access | Times Cited: 40
Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4
Saleha Anwar, Shama Khan, Farah Anjum, et al.
Journal of Cellular Biochemistry (2021) Vol. 123, Iss. 2, pp. 359-374
Closed Access | Times Cited: 37
Probing the interaction of memantine, an important Alzheimer's drug, with human serum albumin: In silico and in vitro approach
Fahad A. Alhumaydhi, Mohammad Abdullah Aljasir, Abdullah S. M. Aljohani, et al.
Journal of Molecular Liquids (2021) Vol. 340, pp. 116888-116888
Closed Access | Times Cited: 36
Mechanistic insight into the binding of graphene oxide with human serum albumin: Multispectroscopic and molecular docking approach
Afroz Khan, Fauzia Anis Khan, Moyad Shahwan, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 256, pp. 119750-119750
Closed Access | Times Cited: 33
Targeting cyclin‐dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies
Mohd Yousuf, Anas Shamsi, Aarfa Queen, et al.
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 8, pp. 897-910
Closed Access | Times Cited: 32
Mechanistic Insight into Binding of Huperzine A with Human Serum Albumin: Computational and Spectroscopic Approaches
Anas Shamsi, Moyad Shahwan, Mohd Shahnawaz Khan, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 797-797
Open Access | Times Cited: 23
Interaction of a cobalt(III) complex containing β-amino alcohol with human serum albumin (HSA): Spectroscopic and molecular docking methods
Nahid Shahabadi, Saba Hadidi, Zahra Abdoli, et al.
Journal of Molecular Liquids (2023) Vol. 384, pp. 122187-122187
Closed Access | Times Cited: 14
Linagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches
Akhtar Atiya, Debarati Das Gupta, Abdulrhman Alsayari, et al.
ACS Omega (2023) Vol. 8, Iss. 7, pp. 6423-6430
Open Access | Times Cited: 12
Unveiling the Molecular Interactions Between Human Transferrin and Limonene: Natural Compounds in Alzheimer’s Disease Therapeutics
Mohammed Alrouji, Sabina Yasmin, Mohammad Furkan, et al.
Journal of Alzheimer s Disease (2024) Vol. 99, Iss. 1, pp. 333-343
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top